Cord Blood contains a very rich source of stem cells that can treat more than 80 diseases. This is the process of collecting life-saving stem cells placenta and umbilical cord and storing them for future use. These stem cells can be used in treating chronic diseases such as blood disease, cancer, diabetes, immune disease, and genetic disorders. These cells are mainly collected from hospitals, and nursing homes and are stored in a cord blood bank for future use up to 25 years. The government has taken the initiative to support research and clinical trials of cord blood stem cells, this support is driving the interest of investment from healthcare companies and commercialization of cord blood stem cell therapies. Moreover, the rise in autoimmune diseases and rising awareness of therapeutics of stem cells are propelling the growth of the market.

The technical improvement in stem cell research and development, storage procedure, and cryopreservation techniques is giving new opportunities to key players to invest in this Cord Blood Banking Service Market.

Furthermore, the rising prices for storing cord blood banking may restrict the market. A patient has to pay for storing and maintenance charges yearly and health insurance companies do not cover cord blood banking which hinders the growth of the market to expand in the forecast period. In 2022, FemiCord group said that within Europe the number of cord banks had dropped by more than 1/3^rd over the past decade.

The rising awareness of cord blood stem cell therapy are major factor that drives the market growth. For instance, the automated processing and storage of cord blood has improved the cost and customer convenience.

Economic Impact of Covid-19:

The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pan\demic era of the Global Cord Blood Banking Services Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs. Innovations by market players and an increasing number of products will propel the growth of this market.

The COVID-19 outbreak has affected the growth of this market due to the lockdown and this delay in the supply and collection of cord blood that is used to treat disease.  The number of chronic patients increasing day by day is the major restraining factor of the Cord Blood Banking Services Market.

Key Players:

• LifeCell
• StemCyte Inc.
• BrainStorm Cell Limited
• Celgene Corporation
• Cryo-Cell International
• Cordlife Group Limited
• Singapore Cord Blood Bank
• Cryo-Save Group AV
• Cord Blood America Inc.
• CBR Systems Inc.
• ViaCord Inc
• China Cord Blood Corporation
• AMAG Pharmaceuticals Inc.
• Americord Registry LLC
• Esperite N.V.
• Others

The above key players in the Global Cord Blood Banking Services Market can be changed according to the client’s requirements.

Moreover, the key players aim towards expansion, joint ventures, collaboration, mergers, and acquisitions to advance capabilities in the Cord Blood Banking Services Market. In recent years there have been many mergers and acquisitions in private cord blood banks owned by the same parent company with different names. For instance, in Spain 4 out of 9 brands are subsidiaries of FamiCord Group, whereas in Mexico 3 out of 6 brands are owned by CryoHoldCo. 

Recent Developments in Global Cord Blood Banking Services Market.

Sanpower dominates the Asian market as Sanpower owns Global Cord Blood Corporation and other assets across Southeast Asia controlling approximately 1.2 million units.

CryoHoldCo holds the strongest stem cell banking assets across LATAM which includes 1 in Peru, 4 in Mexico, 2 in Brazil, and Columbia around 300,000 units.

Global Cord Blood Banking Services Market: Key Benefits:

1. The report provides information regarding key drivers, restraints, and opportunities with impact analysis.
2. Quantitative and Qualitative analysis of the current market.
3. Estimations for the forecast period 2033.
4. Historical data and forecast data.
5. Recent developments and trends in the market.   
6. Market share of the market players, company profiles, SWOT analysis, and competitive landscape.
7. Covid-19 Impact analysis

Global Cord Blood Banking Services Market Segmentation:

By Component:

• Cord Blood
• Cord Tissue

By Application:

• Blood Disease
• Cancer Disease
• Immune Disorders
• Bone-marrow failure syndrome
• Metabolic Disorders

By Storage:

• Private Cord Blood Banks
• Public Cord Blood Banks

By End User:

• Hospitals
• Pharmaceutical Research
• Research Institutes

By Region:

Asia-Pacific

• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia-Pacific

North America

• US
• Canada
• Mexico

Europe

• Germany
• France
• Italy    
• Spain
• UK
• Rest of Europe

The rest of the World

Each of the market segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and competitive analysis.

Research Scope:

Report Scope	Details
Base Year	2023
Historical Years	2019 to 2022
Forecast Years	2024 to 2033
Market Size 2023	USD 33.8 BN
Market Revenue 2033	USD 65.9 BN
Growth Rate 2024- 2033	7.9 %
Report Coverage	Trends, SWOT Analysis, Competitive Landscape, DROs, Revenue Forecast, PEST Analysis.
Segments Covered	Components, Application Storage, End-User, Region
Companies Mentioned	LifeCell, StemCyte Inc., BrainStorm Cell Limited, Celgene Corporation, Cryo-Cell International, Cordlife Group Limited, Singapore Cord Blood Bank, Cryo-Save Group AV, Cord Blood America Inc., CBR Systems Inc., ViaCord Inc, China Cord Blood Corporation, AMAG Pharmaceuticals Inc., Americord Registry LLC, Esperite N.V.
Customization	Yes

 

Regional Analysis:

North America accounted for the largest market share due to the well-developed healthcare infrastructure, growing awareness of stem cells, and increasing healthcare expenditure. An increasing number of genetic disorders like Down syndrome among newborn babies is holding a significant revenue share in the United States. According to the CDC, in the U.S. around 6000 babies are born with Down Syndrome each year, a most common chromosomal disorder. Increasing prevalence of various cancers such as lymphomas and leukemias among all ages.   According to the Leukemia and Lymphoma Society, approximately 89,380 people in the US are diagnosed with Lymphomas, and 59,610 for Leukemia which is around in 2023. Around 4,37,337 people are living or surviving leukemia in the U.S. and is 6,11,720 cancer deaths are projected to occur in 2024

The presence of key players is investing due to rising awareness of the benefits of cord blood and stem cells, and technological advancement is favoring this market in the North American region. 

Europe’s Cord Blood Banking Services Market accounts for 2^nd largest market share due to its increasing patient of chronic disease and the presence of large and giant blood banks in the European region. The Cord Blood bank industry is steadily expanding here due to knowledge of the advantages of cord blood and favorable legal frameworks that boost the market growth.

According to European Commission forecasts, cancer cases are set to rise by almost 25% by 2035.

Key questions answered by this report.

1. Top market players contributing to the revenue?
2. Trending strategies by the players?
3. Which region will be the leading one in the forecast period?
4. Factors that drive the Global Cord Blood Banking Services Market?
5. Which factors will affect the Global Cord Blood Banking Services Market?
6. How Covid-19 pandemic impacted the growth of the Global Cord Blood Banking Services Market?
7. Which Segment accounted for the Global Cord Blood Banking Services Market shares?

Frequently Asked Questions (FAQ) :